Holocene Advisors’s Teladoc Health TDOC Stock Holding History

Holocene Advisors’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-4,589	Closed	-$227K	–	795
2018 Q4	$227K	Buy	+4,589	New	+$281K	﹤0.01%	606

Other funds holding TDOC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

ZCI

Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Holocene Advisors's TDOC Position: Q1 2019 in Review

Holocene Advisors sold out of Teladoc Health (TDOC) in Q1 2019, closing a stake of 4,589 shares — an estimated $227K sold.

Holocene Advisors first reported a position in TDOC in Q4 2018 and held it in 1 quarter. The position peaked at $227K in Q4 2018. 364 funds tracked by Wall St. Rank hold TDOC as of Q1 2019.

Holocene Advisors reported no remaining Teladoc Health position as of Q1 2019 after selling out during the quarter.
Holocene Advisors sold 4,589 Teladoc Health shares in Q1 2019, an estimated $227K.
Holocene Advisors first reported a position in Teladoc Health in Q4 2018 and held it in 1 quarter.
Holocene Advisors's Teladoc Health position peaked at $227K in Q4 2018.
364 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2019.

Based on Holocene Advisors's 13F filing for Q1 2019, filed 15 May 2019.